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Abstract
OBJECTIVE: To evaluate the effect of fermented ex-
tract of Kushen (Radix Sophorae Flavescentis) or
non-fermented ESF on laryngeal neoplasms Hep2
cells.
METHODS: Use 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide (MTT) assay to explore
the effect of fermented ESF and non-fermented ESF
on Hep2 cells, and detect the mRNA and protein ex-
pression level of Bcl-2, Bax and Caspase-3 with re-
verse transcription polymerase chain reaction
(RT-PCR) andWestern blot.
RESULTS: Both fermented ESF and non-fermented
ESF could inhibit laryngeal neoplasm's Hep2 cells,
but and the cells did not response to the dilution 1∶
320 of fermented ESF, nor to the 1∶1280 dilution of
non-fermented ESF. As time progressed, the dilu-
tion 1∶80 of fermented ESF and 1∶320 dilution of
non-fermented ESF could significantly reduce Bcl-2
mRNA and protein expression and down-regulate
Caspase-3 mRNA and protein expression. Bax
mRNA and protein were not expressed in Hep2
cells.
CONCLUSIONS: Both fermented ESF and non-fer-
mented ESF could inhibit the proliferation of Hep2
cells, and the effect of non-fermented ESF was sig-
nificantly better than that of the fermented.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Laryngeal carcinoma is a disease in which tumor cells
grow in the larynx, and its incidence has increased sig-
nificantly.1 Resent studies show that inducing tumor
cell apoptosis is the mechanism and the biological ef-
fect of inhibiting tumor cells in the treatment of many
tumors, which is much more obvious in the process of
chemotherapy.2,3 Many medicines in treatment of tu-
mors have the ability to induce tumor cell apoptosis,
such as cis-platinum, fluorouracil and paclitaxel, all of
which can induce the apoptosis of laryngeal carcinoma
cells.4
Kushen (Radix Sophorae Flavescentis) is the dried roots
of Sophora Flavescens Ait. It contains alkaloids includ-
ing matrine and oxymatrine which are the major effec-
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tive components.5 Modern pharmacological experi-
ments show that the alkaloids in Kushen (Radix Sopho-
rae Flavescentis) have a variety of pharmacological activ-
ities and its anti-neoplastic effect has become a hot top-
ic in recent years. Its anti-neoplastic mechanism in-
cludes inhibiting the proliferation of tumor cells, and
inducing the differentiation and apoptosis of tumor
cells,6 possessing anti-neoplastic property showing ef-
fect on a variety of tumors, such as the cancers of liver,
lung, stomach and bowel.7 Few studies report the effect
of Kushen (Radix Sophorae Flavescentis) on the laryngo-
carcinoma, and only one revealed that oxymatrine had
the effect on laryngocarcinoma. The mechanism was
that oxymatrine might inhibit the proliferation of la-
ryngeal carcinoma Hep2 cells and induce apoptosisin
them, and the apoptotic pathway was up-regulating
Bax expression and the down-regulating Bcl-2 expres-
sion.8
It is still not so sure whether Kushen (Radix Sophorae
Flavescentis), containing large amount of oxymatrine,
really has significant inhibitory effect on laryngeal neo-
plasm and whether the mechanism is consistent with
that the study reported, or whether other components
in it have the effect. So we intend to study the effect of
the extracts of Kushen (Radix Sophorae Flavescentis)
(ESF) before and after solid-state fermentation on la-
ryngeal carcinoma Hep2 cells and the mechanism be-
hind it.
MATERIALS ANDMETHODS
Cell lines
Hep2 cell line was obtained from Institute of Biochem-
istry and Cell Biology, SIBS (Shanghai Institutes for Bi-
ological Sciences), CAS (Chinese Academy of Scienc-
es), and adherent cultured, cryopreserved in our labora-
tory.
Reagents
RPMI 1640 was bought from GIBCO (Carlsbad, CA,
New York, USA). Newborn calf serum (NCS) was
bought from Hangzhou Soiling Biological Engineering
Materials Co., Ltd. (Zhejiang, China). Trypsin and
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) were purchased from Sigma-Aldrich
Inc. (St. Louis, MO, USA). M-MLV reverse transcrip-
tase, Bcl-2 primers, Bax primers, Caspase-3 primers,
β-actin primers were purchased from Invitrogen Com-
pany (Carlsbad, CA, New York, USA). Taq DNA poly-
merase and DL2000 plus DNA Ladder were bought
from Marrone Bio Innovations (California, USA).
Horseradish peroxidase-labeled goat anti-mouse IgG
and goat anti-rabbit IgG was purchased from Zhong-
shan Golden Bridge Biotechnology Company (Beijing,
China).
Major apparatus
CO2 Constant temperature incubator (TAI ESPEC
CORP, Japan), Inverted microscope and fluorescence
microscope (Olympus, Japan), Enzyme-linked immu-
nosorbent detector, Protein vertical electrophoresis
tank, Trans-Blot (Bio-Rad, California, USA), Trace
high-speed low-temperature centrifuge (ST-21, SOR-
VAIL, Kendro, Connecticut, USA); RT-PCR Kit
(PTC-150, MJ Research, Connecticut, USA), Scanner
and software (Kodak, New York, USA).
Cell culture
Hep2 cells were cultured in RPMI 1640 medium con-
taining 10% fetal calf serum (by 56oC, 30 min inacti-
vated), 1×105U/Lpenicillin and 10mg/L streptomycin.
Cell cryopreservation
Cells in logarithmic phase were inoculated in freezing
medium which contained 60% sterile complete medi-
um, 30% NCS, 10% DMSO and bacteria removed by
0.22 µm filtration membranes. Then cells were collect-
ed by centrifuging, diluted in sterile complete medium.
10 µL of the cell suspension was injected into cell
counting chamber and stood for 1 min, then observed
and counted under microscope. Finally, supernatant
was removed after the collected cells were centrifuged
at 1000 r/min for 10 min, and the cells re-suspended
in suspension (106-107 cells/mL) of freezing medium.
The cells suspension was dispensed into sterile cryo-
preservation tubes and placed in -70oC refrigerator for
2 h, and then frozen into liquid nitrogen within
15-30 min.
Cells recovery
Cryopreservation tubes were taken out from the liquid
nitrogen and immediately put into the 40oC water
bath and constantly oscillated until its contents were
completely dissolved. The cell suspension in cryopreser-
vation tubes was transferred to a centrifuge tube, after
10 mL of complete medium were added and it was cen-
trifuged by 1000 r/min for 10 min. The cells precipita-
tion was diluted with fresh medium after removing su-
pernatant, then inoculated in culture bottles and culti-
vated at 37oC. Next day, replaced the medium and con-
tinued to culture.
Morphological observation and cell viability
assessment
Hep2 cells in logarithmic phase were digested with
0.25% trypsin, then washed twice with sterile phos-
phate-buffered saline (PBS), collected and counted
with the same method mentioned in the section of
"Cell cryopreservation". The cell concentration was ad-
justed to 1 × 105 cells/mL by RPMI 1640 medium,
100 µL/well, cultured for 12 h at 37oC in 5% CO2 in-
cubator. After the cells adhered, the extracts of Kushen
(Radix Sophorae Flavescentis) with and without fermen-
tation (diluted 1∶20, 1∶40, 1∶80, 1∶160, 1∶320, 1∶
640, 1∶1280, 1∶2560, 1∶5120 with RPMI 1640 com-
plete medium) were added respectively. Four parallel
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wells were set up for all groups: fermented ESF group
and non-fermented ESF group, and zero adjustment
hole of complete medium established as well.
After 48 h of incubation at 37oC in 5% CO2 incuba-
tor, morphological changes were observed and photo-
graphed under the microscope. After adding MTT
(5 mg/mL) into thewells (10 µL/well), incubationwas re-
sumed for 4 h under the same condition. The cells were
centrifuged by 4000 r/min for 20 min, with discarding
100 µL supernatant and refilling 100 µL 0.01 mol/L
HCl 10% SDS solution, then placed in 5% CO2 incu-
bator at 37oC overnight to fully dissolve the precipita-
tion. The inhibition rate was calculated according to
the formula (A-B)/A×100 (A and B were OD values of
fermentation group and non-fermentation group re-
spectively) after that the OD values were measured at
570 nm using enzyme-linked immunosorbent assay.
Culture Hep2 cells for RT-PCR and Western Blot
Hep2 cells were cultured in expanded scale, and har-
vested that were in logarithmic phase in time periods
of 24, 48 and 72 h respectively after exposed to fer-
mented extract (dilution 1∶80) and unknot-fermented
extract (dilution 1∶320) of Kushen (Radix Sophorae
Flavescentis). A control was set at the same time. Then
the cells were frozen at -20oC for RT-PCR and Western
Blot detecting.
RNA isolation and RT-PCR
Total RNA was extracted utilizing guanidine thiocya-
nate method and was dissolved in deionized water with-
out Rnase. The reverse transcription reaction was per-
formed at 37oC for 60 min and terminated by heating
at 95oC for 10 min. PCR was performed following the
instruction of Taq DNA polymerase under the follow-
ing conditions: pre-degeneration at 95oC for 5 min, de-
generation at 94oC for 1 min, renaturation at 55oC for
1 min, and elongation at 72oC for 7 min, for a total of
30 cycles. All experiments were conducted 3 times.
The primers of Bcl-2, Bax, Caspase-3 and β-actin (Invi-
trogen, Carlsbad, CA, USA) were as follows.
Bcl-2 (318 bp): 5'-cgacgacttctcccgccgctaccgc-3' (P1);
5'-ccgcatgctggggccgtacagttcc-3' (P2). Bax (257 bp):
5'-tccaccaagaagctgagcgag-3' (P1); 5'-gtccagcccatgatg-
gttct-3' (P2). Caspase-3 (358 bp): 5'-cccatttctccatacg-
cact-3' (P1); 5'-tgacagccagtgagacttgg-3' (P2). β-actin
(539bp): 5'-gtggggcgccccaggcacca-3' (P1); 5'-ctccttaat-
gtcacgcacgattt-3' (P2).
PCR products were loaded onto 1.2% agarose gel for
electrophoresis. Gel electrophoresis image was fed into
the Kodak gel analysis system with β-actin as an inner
reference, and the expression intensity was analysed
with 1D Image Analysis Software.
Protein extraction and Western blot analysis
Cell lysis buffer was adding into the cell sedimentation
which was collected respectively at 24, 48 and 72 h un-
der the action of the ESF before and after fermentation
severally, then blew and percussed slightly to make it
steadily disperse and put into ice-bath for 30 min. Su-
pernatant was collected after that cell lysates was centri-
fuged by 10 000 g for 20 min and its protein concen-
tration was determined with BCA Protein Assay Kit.
Samples were added the same volume of 2´loading buf-
fer, then centrifuged after boil-bath for 5 min, and
loaded onto sodium dodecyl Polyacrylamide Gel Elec-
trophoresis (SDS-PAGE, 7.5% stacking gel and 14%
separating gel), followed by a separation and subse-
quent transfer to a nitrocellulose (NC) membrane. The
membrane was blocked in 5% defatted milk for 1-2 h
at room temperature, incubated in the first antibodies
(mouse anti-human Bcl-2, rabbit anti-human Cas-
pase-3, rabbit anti-human Bax or rabbit anti-human ac-
tin). After washed with PBS, the membrane was incu-
bated with horseradish peroxidase-labeled goat anti-rab-
bit or goat anti-mouse secondary antibodies. The im-
age was obtained from X-ray plate exposed in dark
room through Western blot kit and electrochemilumi-
nescence kit, and processed similarly with the above
method.
Data analysis
One-way ANOVA and student's t-test were performed
to compare the differences between groups. P<0.05
was the significant level.
RESULTS
The effects of fermented ESF and non-fermented ESF
on morphological changes and cell viability in Hep2
cells.
The morphology of Hep2 cells after respectively ex-
posed to fermented ESF and non-fermented ESF was
observed by microscope (Figure 1, 2). The result of
MTT experiment showed that the inhibitory rate de-
creased as the solution was further diluted for both fer-
mented ESF and non-fermented ESF, and the cells re-
sponded neither to the dilution 1∶320 of fermented
ESF nor to the dilution1∶1280 of non-fermented ESF,
Figure 1 Morphology of Hep2 cells exposed to different dilutions of fermented ESF and negative control
ESF: etract of Kushen (Radix Sophoae Flavescentis). A: dilution 1∶40, B: dilution 1∶160, C: dilution 1∶320, D: negative control.
A B C D
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which suggested that the latter was more effective than
the former. Hence, we selected the dilution 1∶80 of fer-
mented ESF and the dilution 1∶320 of non-fermented
ESF to explore the mechanism underlying effect of
Kushen (Radix Sophorae Flavescentis) on laryngeal neo-
plasm.
Alteration in expression of Bcl-2, Caspase-3 and Bax
mRNA in Hep2 cells
We selected three kinds of apoptosis-related genes in-
cluding Bcl-2, Bax and Caspase-3 to study the mecha-
nism underpinning the effect of fermented ESF or
non-fermented ESF on Hep2 cells. The result revealed
that, Bcl-2 mRNA expression was down-regulated sig-
nificantly as time progressed, the expression of Cas-
pase-3 mRNA suppressed slightly, and negative expres-
sion of Bax mRNA was detected in Hep2 cells treated
with the dilution 1∶80 of fermented-ESF and the dilu-
tion 1∶320 of non-fermented-ESF (Figure 3, 4).
Alteration in expression of Bcl-2, Caspase-3 and Bax
protein in Hep2 cells
The expression levels were determined with Western
Blot. It showed that as time progressed, Bcl-2 protein
expression decreased significantly, the expression of
Caspase-3 protein down-regulated slightly, and that
Bax protein was not expressed in Hep2 cells (Figure 5,
6). The result was consistent with that of RT-PCR.
DISCUSSION
In preliminary study, it was easy to extract the bio-ac-
tive ingredients of Kushen (Radix Sophorae Flavescentis)
after solid-state fermentation. By determined the con-
tent of matrine and oxymatrine before and after sol-
id-state fermentation respectively, it was found that ma-
trine increased while oxymatrine decreased in the ex-
tracts after fermentation.9 This suggested that some of
the oxymatrine might transformed into matrine in the
process of fermentation. The reason might be that the
nitrogen-oxygen bond in oxymatrine was broken and
then it transformed into matrine caused by the action
of microorganism and their enzymes.10
The study indicated that both fermented ESF and
non-fermented ESF could inhibit the growth of laryn-
geal carcinoma Hep2 cells, and non-fermented ESF
had stronger inhibitory effect than fermented ESF. The
reason might be that there were more oxymatrine in
non-fermented ESF because part of oxymatrine lost
due to fermentation.
The study suggested the mechanism of inhibitory ef-
fect on laryngeal carcinoma cells did not change before
and after fermentation. Oxymatrine in Kushen (Radix
Sophorae Flavescentis) was the effective component
Figure 2 Morphology of Hep2 cells exposed to different dilutions of non-fermented ESF and negative control
ESF: extract of Kushen (Radix Sophoae Flavescentis). A: dilution 1∶80; B: dilution 1∶640; C: dilution 1∶2560; D: negative control.
A B C D
Figure 5 Bcl-2, Caspase-3 and Actin protein expression ex-
posed to non-fermented ESF (dilution 1∶80) in Hep2 cells
Bcl-2: B-cell lymphoma 2; Caspase-3: Cys-teinylaspartate
specific proteinase 3; ESF: extract of Sophorae flavescentis.
1: without treatment; 2: 24 h; 3: 48 h; 4: 72 h.
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Figure 6 Bcl-2, Caspase-3 and Actin protein expression ex-
posed to fermented ESF (dilution 1∶320) in Hep2 cells
Bcl-2: B-cell lymphoma 2; Caspase-3: Cys-teinylaspartate
specific proteinase 3; ESF: extract of Sophorae flavescentis.
1: without treatment; 2: 24 h; 3: 48 h; 4: 72 h.
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Figure 3 The RT-PCR results of Bcl-2 mRNA expression in
Hep2 cells
FJ: fermentation; WFJ: without fermentation; RT-PCR: reverse
transcription-polymerase chain reaction.
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Figure 4 The RT-PCR results of Caspase-3 mRNA expression
in Hep2 cells
FJ: fermentation; WFJ: without fermentation; RT-PCR: reverse
transcription-polymerase chain reaction.
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against laryngeal tumor, which could decrease Bcl-2 ex-
pression and Caspase-3 expression.
Using both RT-PCR and Western blot to detect
mRNA and protein expression levels of Bcl-2, Bax and
Caspase-3, Bax was not expressed in Hep2 cells, which
was inconsistent with the literature report that oxyma-
trine could up-regulate Bax expression.8 The reason
may be that, because the extract in our study included
both the non-fermented and fermented, other un-
known ingredients might be extracted out as well dur-
ing the process of fermentation. Further study should
be carried out to explore the answer.
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